Novel Nucleoside Reverse Transcriptase Inhibitor Derivatives for Chronic Neuropathic Pain

Pharmacology, Toxicology and Pharmaceutical Science

1. RNA Directed DNA Polymerase Inhibitor 100%
2. Neuropathic Pain 100%
3. Inflammasome 63%
4. Synapsin II 54%
5. Zidovudine 54%
6. Stavudine 45%
7. Lamivudine 36%
8. Interleukin 1beta Converting Enzyme 36%
9. Purinergic P2X7 Receptor 27%
10. Inflammatory Pain 18%
11. Chronic Pain 18%
12. Abacavir 18%
13. Adenosine Triphosphate 18%
14. Interleukin 1 18%
15. Reverse Transcriptase 18%
16. Mechanical Hyperalgesia 9%
17. Chronic Inflammatory Pain 9%
18. Western Blot 9%
19. Cell Culture 9%
20. Genotoxicity 9%
21. Cytokine 9%
22. Fatty Liver 9%
23. Nerve Transection 9%
24. Interleukin 18 9%
25. High Performance Liquid Chromatography 9%
26. Mitochondrial DNA 9%
27. HIV 9%
28. Enzyme-Linked Immunosorbent Assay 9%
29. Multiprotein Complex 9%
30. Zalcitabine 9%
31. Bacterial Toxin 9%
32. Elimination 9%
33. Analgesic Agent 9%
34. Placebo 9%
35. Knockout Mouse 9%
36. Receptor 9%
37. Nerve Injury 9%
38. DNA Polymerase 9%
39. Lactic Acidosis 9%
40. Mechanical Allodynia 9%
41. Drug Absorption 9%
42. Hyperalgesia 9%
43. Ethambutol 9%
44. Deoxyguanosine 9%
45. Neuropathy 9%
46. Pharmacokinetics 9%
47. Cholesterol 9%
48. Virus 9%
49. Adverse Event 9%